Products for Research Use Only
RegisterLogin

Peficitinib (hydrobromide)

CAT: 0804-HY-19568ASize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-19568ASize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Peficitinib (ASP015K) hydrobromide is an orally active JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively[1].
CAS Number
1353219-05-2
Product Name Alternative
ASP015K (hydrobromide) ; JNJ-54781532 (hydrobromide)
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/peficitinib-hydrobromide.html
Solubility
10 mM in DMSO
Smiles
O[C@](C[C@@H]1C[C@H]2C3)(C2)C[C@@H]3[C@H]1NC4=C5C(NC=C5)=NC=C4C(N)=O.Br[H]
Molecular Formula
C18H23BrN4O2
Molecular Weight
407.30
References & Citations
[1]Ito M, et al. A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model. J Pharmacol Sci. 2017 Jan;133 (1) :25-33.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
JAK1; JAK2; JAK3; Tyk2

Related Products

CatalogName
HY-19568-01Peficitinib
HY-19568R-01Peficitinib (Standard)
HY-19568BPeficitinib (hydrochloride)
HY-108723Dihydrogalanthamine (hydrobromide)
HY-W206168-01Tetrahydropapaveroline (hydrobromide)
HY-145119AS-01Mindeudesivir (hydrobromide)
HY-14744CLevamlodipine (hydrobromide)
HY-N2482A-01Guvacine (hydrobromide)
HY-127022AAnisodine (hydrobromide)
HY-18200BAtopaxar (hydrobromide)

Alternative Products

CatalogName
T33905-01Peficitinib hydrobromide
MBS131751-01Peficitinib
T61365-01Peficitinib hydrochloride

Popular Products